The Secretary shall request the United States Pharmacopeia Convention to develop, in consultation with pharmaceutical benefit managers and other interested parties, a list of categories and classes that may be used by prescription drug plans under this paragraph, and to revise such classification from
credit:
time to time to reflect changes in therapeutic uses of covered Part D drugs and the additions of new covered Part D drugs.